Habituation's Mechanisms in Preterm and Term Infants
HABIPREMA
1 other identifier
observational
70
1 country
1
Brief Summary
Each year in France, 7 % of newborns are born preterm (before 37 weeks of gestational age (GA)). The investigators called very preterm infants those who were born before 33 weeks of GA. These very preterm infants have a higher risk of developing neurological complications like developmental disabilities or cerebral palsy. To date, early assessment of these infants is difficult and not reliable enough to detect those who are at risks of developing neurological issues. Now, the investigators need to identify earlier these infants to provide them interventions to improve their development (physical therapy for example). Consequently, the investigators are examining a study whose aim is to assess preterm infants habituation. Habituation is the newborn ability to become familiar with new environmental stimulations (noise, light…). This habituation allows the newborn to maintain his sleep even at onset of a noise or light. To study this phenomenon in infants born preterm near to corrected term (around 40 weeks of postnatal GA), will allow us to better understand neurological development of these infants. The investigators plan to compare habituation skills of preterm infants near to their theorical date of birth (40 weeks of GA) to a population of infants born at term. The investigators will also study the link between habituation abilities and sleep quality as well as neurodevelopmental outcome at the corrected age of two years old.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2015
CompletedStudy Start
First participant enrolled
July 9, 2015
CompletedFirst Posted
Study publicly available on registry
July 14, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
September 16, 2025
September 1, 2025
11.5 years
July 9, 2015
September 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of the package n°1 of the APIB (Assessment of Premature Infant's Behaviour)
At 40 weeks of postnatal gestational age for the preterm infants and at 3 days old for the term newborns
Secondary Outcomes (6)
Salivary cortisol changes
Before and 30 minutes after the package n°1 of the APIB achievement
Oxy and deoxyhemoglobin changes in NIRS (Near-infrared Spectroscopy)
During APIB package n°1 fulfillment
Heart rate variations
During APIB package n°1 fulfillment
Oxymetry variations
During APIB package n°1 fulfillment
Brief Infant Sleep Questionnaire
At 6 and 12 months old (corrected age for the preterm infants)
- +1 more secondary outcomes
Study Arms (2)
Preterm infants
Preterm infants born between 25 weeks and 32 weeks + 6 days of gestation
Term newborns
Infant born at term
Interventions
Eligibility Criteria
Preterm infants and term infants born in Brest University Hospital
You may qualify if:
- Preterm infants: preterm infants born from 25 weeks to 32 weeks + 6 days of gestation near to 36 weeks of gestation (corrected postnatal age)
- Term infants: term newborns with a gestational age between 39 and 41 weeks of gestation at day 3 with an Apgar ≥ 1 at 1 minute of life
- For both groups: normal neurological physical examination, written informed consent of the parents
You may not qualify if:
- no malformation or chromosomal abnormality, life threatening disease, administration of morphine or sedatives during the 24 hours before the study, context of maternal drug addiction, deafness, no psychoactive drug or anticonvulsivants during the last month of pregnancy for the term newborns, severe neurological disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Brest
Brest, 29609, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Michel ROUE, Professor
CHRU de Brest
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2015
First Posted
July 14, 2015
Study Start
July 9, 2015
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2029
Last Updated
September 16, 2025
Record last verified: 2025-09